Videos

Jessica Yih, MD, highlights a study assessing vulvar tissue changes among non-diabetic women receiving GLP-1RAs for weight loss.

Kiera Liblik, MD, MSc, shares the background and key findings from the study, “Sex and Gender in Urological Research.”

Daniel A. González Padilla, MD, emphasized that shared decision-making is essential, as patients must weigh potential benefits against adverse effects and the possibility of ultimately requiring radical cystectomy or clinical trial participation.

Health care professionals discuss the vital role of pharmacy teams in managing complex patient care, emphasizing collaboration and medication safety.

Urologists discuss the importance of monitoring cardiovascular health in patients undergoing androgen deprivation therapy for prostate cancer.

Jonathan Yu, MD, highlights a study on early repair of vesicourethral anastomotic leak, which was presented at the 2026 Desai Sethi Urology Institute Urology on the Beach meeting in Miami Florida.

Christopher P. Filson, MD, MS, highlights the evolving role of urine-based biomarkers in the diagnostic workflow for patients who present with microhematuria.

Singh concludes that increasing physician awareness and comfort with low-dose imaging is key to reducing unnecessary radiation while maintaining diagnostic accuracy and patient safety.

Amy Luckenbaugh, MD, FACS, outlines the ways that SWIU supports women across all stages of their urologic careers and the ways women can become involved with the organization.

Alex Tatem, MD, explains that hyaluronic acid penile injections add temporary, measurable girth by safely distributing a reversible filler within soft tissue, though outcomes depend heavily on technique and vary between individuals.

Savannah Grandy, DO, highlights key takeaways from a MUSIC-KIDNEY study comparing single port vs. multiport robotic partial nephrectomy.

Kristen R. Scarpato, MD, MPH, recaps a panel discussion at SWIU 2026 focused on imposter syndrome.

Angela B. Smith, MD, MS, discusses the guiding priorities behind shaping this year’s Society of Women in Urology annual meeting.

Healthcare professionals discuss strategies to manage cardiovascular risks in cancer patients, emphasizing weight control, exercise, and collaboration with primary care.

Healthcare professionals discuss the importance of addressing quality of life and exercise for patients starting androgen deprivation therapy.

Because Break Wave uses lower pressure levels, patient discomfort is minimal, allowing treatments to be performed without sedation.

Francisco Ramos, MD, highlights a study examining the impact of socioeconomic hardship on cancer presentation and survival in testicular cancer.

Christopher P. Filson, MD, MS, highlights a study evaluating the real-world utility of incorporating the CxBladder Triage test to the diagnostic workflow for microhematuria.

To address high no-show rates typical of safety-net settings, JPS implemented proactive scheduling practices.

Sarah Azari, MD, highlights a prospective study examining the impact of perioperative education on demoralization and sexual function in women with bladder cancer.

Veda N. Giri, MD, outlines practical ways to improve prostate cancer genetic testing uptake and impact.

Amy N. Luckenbaugh, MD, FACS, shares what her patients have taught her about resilience as well as some of the advances in urologic oncology that are giving her hope.

Recent trends show a significant increase in the use of combination therapies for advanced cancer, highlighting the need for ongoing education and adaptation.

Experts discuss the complexities of advanced imaging in cancer diagnosis, highlighting challenges with PET scans and the importance of accurate interpretation.

Kate Kraft, MD, MHPE, FACS, FAAP, discusses her SWIU 2026 session on helping early-career urologists find their “leadership flow.”

Break Wave lithotripsy uses low-pressure, repeated pulses that generate standing stress waves within the stone.

Kristen R. Scarpato, MD, MPH, discusses what level of evidence is necessary to shift the standard of care in BCG-naive NMIBC.

Amanda C. North, MD, reflects on key takeaways from a panel discussion on imposter syndrome.

Farah Rahman, MD, MPH, highlights a pilot study on the use of wearable biofeedback technology to better understand and address burnout among urology residents.

Regarding acceptable risk thresholds, Alam describes himself as relatively risk-averse, favoring a 5% to 10% miss rate for Grade Group 2 or higher disease when considering biopsy avoidance.